Quince Therapeutics Price Chart
Quince Therapeutics Volume Chart
Quince Therapeutics Market Segments
After Hours
+0.00(+0.00%)
| Open | $30.20 |
|---|---|
| Close | $30.20 |
| Low | $30.20 |
| Low Change | 0.00 (0.00%) |
| High | $30.20 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 695 |
| Dollar Volume | $20.99K |
Regular Trading Hours
+0.73(+2.44%)
| Open | $29.92 |
|---|---|
| Close | $30.65 |
| Low | $29.25 |
| Low Change | -0.67 (-2.24%) |
| High | $30.77 |
| High Change | +0.85 (+2.84%) |
| Range | $1.52 |
| Volume | 22.726K |
| Dollar Volume | $696.55K |
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $29.54 |
|---|---|
| Close | $29.54 |
| Low | $29.54 |
| Low Change | 0.00 (0.00%) |
| High | $29.54 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 1.017K |
| Dollar Volume | $30.04K |
Regular Trading Hours Yesterday
+0.33(+1.13%)
| Open | $29.17 |
|---|---|
| Close | $29.50 |
| Low | $28.55 |
| Low Change | -0.62 (-2.12%) |
| High | $30.32 |
| High Change | +1.15 (+3.94%) |
| Range | $1.77 |
| Volume | 19.726K |
| Dollar Volume | $581.92K |
Premarket Yesterday
+0.00(+0.00%)
| Open | $28.60 |
|---|---|
| Close | $28.60 |
| Low | $28.60 |
| Low Change | 0.00 (0.00%) |
| High | $28.60 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 200 |
| Dollar Volume | $5.72K |
Quince Therapeutics News
6 months agobenzinga.comWhat Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours
6 months agoinvesting.comQuince Therapeutics stock plummets after revealing strategic alternatives
- 6 months agoinvesting.com
Quince Therapeutics stock soars after engaging LifeSci Capital as advisor
- 6 months agoinvesting.com
Quince Therapeutics stock tumbles after failed Phase 3 trial results
Quince Therapeutics Top Trades
Quince Therapeutics's top trade so far today returned +4.79%, while the top short trade returned -2.24%.
Quince Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $26.91 |
|---|---|
| 10 Day Moving Average (SMA10) | $23.46 |
| 20 Day Moving Average (SMA20) | $20.98 |
| 50 Day Moving Average (SMA50) | $11.25 |
| 100 Day Moving Average (SMA100) | $6.03 |
| 200 Day Moving Average (SMA200) | $4.00 |
Quince Therapeutics Statistics
| Average Volume (30 Days) | 82.24K |
|---|---|
| P/E Ratio (Current) | -.78 |
| EPS (Current) | -$36.97 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$37.73M |
| Cash Ratio | 2.07 |
| Current Ratio | 2.92 |
| Quick Ratio | 2.92 |
| Debt to Equity | 0.00 |
| Enterprise Value | $10.08M |
| EV to EBITDA | -0.19 |
| EV to Sales | — |
| Price to Book | 1.80 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.36% |
| Return on Equity | -2.31% |
Quince Therapeutics Stock Splits
There have been 2 stock splits for Quince Therapeutics (QNCX). The last reverse stock split occured on June 30, 2026 and reduced the outstanding shares at a ratio of 20:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 30, 2026 | Reverse | 20:1 |
| Apr 13, 2026 | Reverse | 10:1 |
Quince Therapeutics Dividends
There have been no dividends for Quince Therapeutics (QNCX).